TL;DR: Plaquenil raises photosensitivity and quietly drives pigment changes over time. Here is a derm-aligned routine for lupus and autoimmune patients on Plaquenil.
TL;DR. Hydroxychloroquine (Plaquenil) is one of the most important medications in lupus and several autoimmune conditions, and it changes your skin in two ways nobody tends to flag upfront: a real increase in photosensitivity, and a slow blue-gray pigmentation that can develop after years of use. The skincare answer is strict mineral SPF, a calming routine, and regular monitoring with a dermatologist.
The phone call I get from autoimmune patients is consistent: “I started Plaquenil and my dermatitis is calmer, but my face burns in five minutes of sun and a strange gray-brown patch has shown up on my shin.” Both of those are common. Both are manageable. Almost no rheumatologist mentions skin care in detail at the prescription visit, which leaves patients to figure it out from forums.
What Plaquenil does to skin
Hydroxychloroquine is a disease-modifying drug used in systemic lupus erythematosus, cutaneous lupus, rheumatoid arthritis, and several other conditions. It modulates immune function in ways that reduce inflammatory activity. The skin effects fall into two categories.
First, photosensitivity. Plaquenil increases sensitivity to UV light, especially UVA. Patients burn faster, develop rashes after brief sun exposure, and find that areas previously tolerant to incidental sun (forearms during a walk, face during a drive) become reactive within minutes.
Second, pigment changes. Around 7 to 25 percent of patients on long-term Plaquenil develop a characteristic blue-gray or slate-colored pigmentation, typically on shins, forearms, the hard palate, and sometimes the face. It usually appears after several years of treatment but can occur earlier. The pigment is not melanin alone; it is a combination of melanin, hemosiderin, and the drug itself deposited in the skin.
What helps
The routine has two priorities: protect from UV aggressively, and keep the skin calm without adding irritants that compound photosensitivity.
Mineral SPF 30 to 50 every morning, no exceptions. Zinc oxide and titanium dioxide block UVA more reliably than most chemical filters, and UVA is the wavelength most relevant to Plaquenil photosensitivity and to underlying lupus skin disease. Reapply every two hours if outdoors. Mineral over chemical is the standard recommendation here.
A wide-brim hat and UPF 50 clothing when spending more than 15 minutes outdoors. SPF on its own is not enough for autoimmune patients on Plaquenil, particularly during summer and at higher altitudes.
A fragrance-free gentle cleanser. Skip foaming sulfates, alcohol toners, and any product with significant essential oils.
Niacinamide 4 to 5 percent serum in the morning. Calming, mildly anti-inflammatory, and pairs well with sunscreen and with the antimalarial chemistry of Plaquenil.
A ceramide-based moisturizer twice daily.
And avoid aggressive actives during the first six months of Plaquenil treatment. Retinoids, AHAs, BHAs, and vitamin C in high concentrations are not contraindicated, but they amplify photosensitivity and irritation in patients whose skin is already reactive. Add them slowly if at all, and only after the underlying disease is well controlled.
The contrarian take: the pigment is mostly UV-driven
The blue-gray Plaquenil pigmentation is often described as an unavoidable side effect of the drug. The data suggest that strict daily UV protection significantly reduces both the rate of pigment development and its eventual severity. The shins develop it most often precisely because they get the most incidental sun, walking outside in shorts and skirts year round. Patients who wear UPF leggings, long pants, or strict daily sunscreen on the legs develop the pigment substantially less often. It is not entirely preventable, but it is far from inevitable.
When to see a dermatologist
Before starting Plaquenil if possible, to establish a baseline of skin findings. Within the first three months of treatment if you develop a new rash, photosensitivity reactions, or pigment changes. Annually thereafter for monitoring of both drug-related skin changes and the underlying autoimmune skin disease (if lupus or dermatomyositis). Plaquenil also requires annual ophthalmology screening for retinal toxicity, separate from the skin monitoring.
If the pigment appears, a dermatologist can confirm the diagnosis, often clinically alone but sometimes with a biopsy. Treatment options for the pigment are limited; some patients see slow lightening over years after stopping the drug, others retain the pigment indefinitely. The clinical decision is almost always to continue Plaquenil despite the cosmetic side effect, because the disease-modifying benefit outweighs the pigment cost.
The real numbers
A 2013 study in JAMA Dermatology of 24 patients with hydroxychloroquine pigmentation found that the median time to onset was 6.1 years of treatment, with cumulative dose strongly correlated to pigment severity. A 2020 review in the Journal of the American Academy of Dermatology reported that 7 to 25 percent of long-term Plaquenil users develop pigment changes, with most cases mild to moderate and well tolerated cosmetically. Photoprotection compliance was the strongest modifiable risk factor.
For more on autoimmune skincare, see our lupus-affected skin routine and the sensitive skin tag hub.
FAQ
Will the pigment go away if I stop Plaquenil? Sometimes. Slow lightening over months to years is possible, but full resolution is not guaranteed. Most patients stay on Plaquenil despite the pigment because the disease benefit is significant.
Can I use retinoids while on Plaquenil? Yes, cautiously. Wait until the underlying disease is well controlled, use them at low frequency, and increase SPF compliance correspondingly.
Why does my skin look gray in winter too? Plaquenil pigment is not seasonal once established. UV drives the initial deposition, but the deposited pigment persists year round.
Is there a sunscreen specifically for autoimmune patients? No specific category, but mineral SPF 50 with broad-spectrum UVA coverage is the standard recommendation. Look for high PPD or PA++++ ratings on the label.
Are tinted sunscreens better? For lupus patients in particular, yes. Iron oxides in tinted mineral sunscreens block visible light, which contributes to lupus skin flares and to melasma alongside UV. More on tinted SPF and visible light.
Sources
Skare T et al. Antimalarial cutaneous side effects: a study in 209 patients. Cutaneous and Ocular Toxicology, 2011. Bahloul E et al. Hydroxychloroquine-induced hyperpigmentation in systemic diseases. JAAD.org/” rel=”noopener” target=”_blank”>Journal of the AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology, 2020. Jallouli M et al. Hydroxychloroquine-induced pigmentation in lupus patients. JAMA Dermatology, 2013.